Stelara induces clinical remission and response in moderate to severe ulcerative colitis Oct. 11, 2018
Ritter presents additional phase IIb data on RP-G28 for treatment of lactose intolerance Oct. 11, 2018
ASSESS trial demonstrates superior efficacy of Gilenya over Copaxone in relapsing-remitting MS Oct. 11, 2018
Perjeta approved in Japan for neoadjuvant and adjuvant use in HER2-positive early breast cancer Oct. 11, 2018
Cognition Therapeutics begins phase II trial of CT-1812 in mild to moderate Alzheimer's disease Oct. 11, 2018
RSS